RT Journal Article
SR Electronic
T1 Single-Cell Analysis Reveals Macrophage-Driven T Cell Dysfunction in Severe COVID-19 Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.23.20100024
DO 10.1101/2020.05.23.20100024
A1 Liu, Xiaoqing
A1 Zhu, Airu
A1 He, Jiangping
A1 Chen, Zhao
A1 Liu, Longqi
A1 Xu, Yuanda
A1 Ye, Feng
A1 Feng, Huijian
A1 Luo, Ling
A1 Cai, Baomei
A1 Mai, Yuanbang
A1 Lin, Lihui
A1 Zhuang, Zhenkun
A1 Chen, Sibei
A1 Shi, Junjie
A1 Wen, Liyan
A1 Wei, Yuanjie
A1 Zhuo, Jianfen
A1 Zhao, Yingying
A1 Li, Fang
A1 Wei, Xiaoyu
A1 Chen, Dingbin
A1 Zhang, Xinmei
A1 Zhong, Na
A1 Huang, Yaling
A1 Liu, He
A1 Wang, Jinyong
A1 Xu, Xun
A1 Wang, Jie
A1 Chen, Ruchong
A1 Chen, Xinwen
A1 Zhong, Nanshan
A1 Zhao, Jingxian
A1 Li, Yi-min
A1 Zhao, Jincun
A1 Chen, Jiekai
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.23.20100024.abstract
AB The vastly spreading COVID-19 pneumonia is caused by SARS-CoV-2. Lymphopenia and cytokine levels are tightly associated with disease severity. However, virus-induced immune dysregulation at cellular and molecular levels remains largely undefined. Here, the leukocytes in the pleural effusion, sputum, and peripheral blood biopsies from severe and mild patients were analyzed at single-cell resolution. Drastic T cell hyperactivation accompanying elevated T cell exhaustion was observed, predominantly in pleural effusion. The mechanistic investigation identified a group of CD14+ monocytes and macrophages highly expressing CD163 and MRC1 in the biopsies from severe patients, suggesting M2 macrophage polarization. These M2-like cells exhibited up-regulated IL10, CCL18, APOE, CSF1 (M-CSF), and CCL2 signaling pathways. Further, SARS-CoV-2-specific T cells were observed in pleural effusion earlier than in peripheral blood. Together, our results suggest that severe SARS-CoV-2 infection causes immune dysregulation by inducing M2 polarization and subsequent T cell exhaustion. This study improves our understanding of COVID-19 pathogenesis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by grants from the National Key Research and Development Program of China (2019YFA0110200, 2018YFC1200100, 2018ZX10301403), the special project for COVID-19 of Guangzhou Regenerative Medicine and Health Guangdong Laboratory(2020GZR110106006), the emergency grants for prevention and control of SARS-CoV-2 of Ministry of Science and Technology (2020YFC0841400) and Guangdong province (2020B111108001, 2018B020207013). We thank the patient who took part in this study. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No related informationsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon reasonable request